The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease

Abstract Background Autologous mesenchymal stem cells (MSCs) have emerged as a therapeutic option for many diseases. Hypertensive kidney disease (HKD) might impair MSCs’ reparative ability by altering the biomolecular properties, but the characteristics of this impairment are unclear. In our previou...

Full description

Bibliographic Details
Published in:Stem Cell Research & Therapy
Main Authors: Gurparneet Kaur Sohi, Naba Farooqui, Arjunmohan Mohan, Kamalnath Sankaran Rajagopalan, Li Xing, Xiang Y. Zhu, Kyra Jordan, James D. Krier, Ishran M. Saadiq, Hui Tang, LaTonya J. Hickson, Alfonso Eirin, Lilach O. Lerman, Sandra M. Herrmann
Format: Article
Language:English
Published: BMC 2024-06-01
Subjects:
Online Access:https://doi.org/10.1186/s13287-024-03778-1
_version_ 1850263649102331904
author Gurparneet Kaur Sohi
Naba Farooqui
Arjunmohan Mohan
Kamalnath Sankaran Rajagopalan
Li Xing
Xiang Y. Zhu
Kyra Jordan
James D. Krier
Ishran M. Saadiq
Hui Tang
LaTonya J. Hickson
Alfonso Eirin
Lilach O. Lerman
Sandra M. Herrmann
author_facet Gurparneet Kaur Sohi
Naba Farooqui
Arjunmohan Mohan
Kamalnath Sankaran Rajagopalan
Li Xing
Xiang Y. Zhu
Kyra Jordan
James D. Krier
Ishran M. Saadiq
Hui Tang
LaTonya J. Hickson
Alfonso Eirin
Lilach O. Lerman
Sandra M. Herrmann
author_sort Gurparneet Kaur Sohi
collection DOAJ
container_title Stem Cell Research & Therapy
description Abstract Background Autologous mesenchymal stem cells (MSCs) have emerged as a therapeutic option for many diseases. Hypertensive kidney disease (HKD) might impair MSCs’ reparative ability by altering the biomolecular properties, but the characteristics of this impairment are unclear. In our previous pre-clinical studies, we found hypoxic preconditioning (HPC) enhanced angiogenesis and suppressed senescence gene expression. Thus, we hypothesize that HPC would improve human MSCs by enhancing their functionality and angiogenesis, creating an anti-inflammatory and anti-senescence environment. Methods MSC samples (n = 12 each) were collected from the abdominal fat of healthy kidney donors (HC), hypertensive patients (HTN), and patients with hypertensive kidney disease (HKD). MSCs were harvested and cultured in Normoxic (20% O2) or Hypoxic (1% O2) conditions. MSC functionality was measured by proliferation assays and cytokine released in conditioned media. Senescence was evaluated by senescence-associated beta-galactosidase (SA-beta-gal) activity. Additionally, transcriptome analysis using RNA-sequencing and quantitative PCR (qPCR) were performed. Results At baseline, normoxic HTN-MSCs had higher proliferation capacity compared to HC. However, HPC augmented proliferation in HC. HPC did not affect the release of pro-angiogenic protein VEGF, but increased EGF in HC-MSC, and decreased HGF in HC and HKD MSCs. Under HPC, SA-β-gal activity tended to decrease, particularly in HC group. HPC upregulated mostly the pro-angiogenic and inflammatory genes in HC and HKD and a few senescence genes in HKD. Conclusions HPC has a more favorable functional effect on HC- than on HKD-MSC, reflected in increased proliferation and EGF release, and modest decrease in senescence, whereas it has little effect on HTN or HKD MSCs.
format Article
id doaj-art-e3f87e4acdf64951aa98a88b3a081f2b
institution Directory of Open Access Journals
issn 1757-6512
language English
publishDate 2024-06-01
publisher BMC
record_format Article
spelling doaj-art-e3f87e4acdf64951aa98a88b3a081f2b2025-08-19T23:45:51ZengBMCStem Cell Research & Therapy1757-65122024-06-0115111510.1186/s13287-024-03778-1The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney diseaseGurparneet Kaur Sohi0Naba Farooqui1Arjunmohan Mohan2Kamalnath Sankaran Rajagopalan3Li Xing4Xiang Y. Zhu5Kyra Jordan6James D. Krier7Ishran M. Saadiq8Hui Tang9LaTonya J. Hickson10Alfonso Eirin11Lilach O. Lerman12Sandra M. Herrmann13Division of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicDivision of Nephrology and Hypertension, Mayo ClinicAbstract Background Autologous mesenchymal stem cells (MSCs) have emerged as a therapeutic option for many diseases. Hypertensive kidney disease (HKD) might impair MSCs’ reparative ability by altering the biomolecular properties, but the characteristics of this impairment are unclear. In our previous pre-clinical studies, we found hypoxic preconditioning (HPC) enhanced angiogenesis and suppressed senescence gene expression. Thus, we hypothesize that HPC would improve human MSCs by enhancing their functionality and angiogenesis, creating an anti-inflammatory and anti-senescence environment. Methods MSC samples (n = 12 each) were collected from the abdominal fat of healthy kidney donors (HC), hypertensive patients (HTN), and patients with hypertensive kidney disease (HKD). MSCs were harvested and cultured in Normoxic (20% O2) or Hypoxic (1% O2) conditions. MSC functionality was measured by proliferation assays and cytokine released in conditioned media. Senescence was evaluated by senescence-associated beta-galactosidase (SA-beta-gal) activity. Additionally, transcriptome analysis using RNA-sequencing and quantitative PCR (qPCR) were performed. Results At baseline, normoxic HTN-MSCs had higher proliferation capacity compared to HC. However, HPC augmented proliferation in HC. HPC did not affect the release of pro-angiogenic protein VEGF, but increased EGF in HC-MSC, and decreased HGF in HC and HKD MSCs. Under HPC, SA-β-gal activity tended to decrease, particularly in HC group. HPC upregulated mostly the pro-angiogenic and inflammatory genes in HC and HKD and a few senescence genes in HKD. Conclusions HPC has a more favorable functional effect on HC- than on HKD-MSC, reflected in increased proliferation and EGF release, and modest decrease in senescence, whereas it has little effect on HTN or HKD MSCs.https://doi.org/10.1186/s13287-024-03778-1Hypertensive kidney diseaseAdipose mesenchymal stem cellsHypoxia preconditioningAngiogenesisSenescence
spellingShingle Gurparneet Kaur Sohi
Naba Farooqui
Arjunmohan Mohan
Kamalnath Sankaran Rajagopalan
Li Xing
Xiang Y. Zhu
Kyra Jordan
James D. Krier
Ishran M. Saadiq
Hui Tang
LaTonya J. Hickson
Alfonso Eirin
Lilach O. Lerman
Sandra M. Herrmann
The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease
Hypertensive kidney disease
Adipose mesenchymal stem cells
Hypoxia preconditioning
Angiogenesis
Senescence
title The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease
title_full The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease
title_fullStr The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease
title_full_unstemmed The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease
title_short The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease
title_sort impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease
topic Hypertensive kidney disease
Adipose mesenchymal stem cells
Hypoxia preconditioning
Angiogenesis
Senescence
url https://doi.org/10.1186/s13287-024-03778-1
work_keys_str_mv AT gurparneetkaursohi theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT nabafarooqui theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT arjunmohanmohan theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT kamalnathsankaranrajagopalan theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT lixing theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT xiangyzhu theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT kyrajordan theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT jamesdkrier theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT ishranmsaadiq theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT huitang theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT latonyajhickson theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT alfonsoeirin theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT lilacholerman theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT sandramherrmann theimpactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT gurparneetkaursohi impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT nabafarooqui impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT arjunmohanmohan impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT kamalnathsankaranrajagopalan impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT lixing impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT xiangyzhu impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT kyrajordan impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT jamesdkrier impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT ishranmsaadiq impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT huitang impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT latonyajhickson impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT alfonsoeirin impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT lilacholerman impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease
AT sandramherrmann impactofhypoxiapreconditioningonmesenchymalstemcellsperformanceinhypertensivekidneydisease